Abstract / Summary
Abstract Provided herein are novel aminocyclohexenyl-6,6-bicyclic compounds as 5-HT2A receptor agonists, pharmaceutical compositions, use of such compounds in treating depression, anxiety, substance abuse and headaches, and processes for preparing such compounds.
Topics
Treatment of Major Depression5-HT2A receptor agonistsserotonin receptor agonistsdepressionanxietysubstance abuseheadachedrug formulationcompound synthesisOpen access